Welcome to our dedicated page for Trilogy AI news (Ticker: TRAIF), a resource for investors and traders seeking the latest updates and insights on Trilogy AI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trilogy AI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trilogy AI's position in the market.
Trilogy AI Corp (CSE: TRAI) (OTCQB: TRAIF) announces multiple concurrent offerings: (i) a LIFE Offering of up to 7M common shares at C$0.07 per share for C$490,000, (ii) a Private Placement of up to 5M shares at C$0.07 for C$350,000, and (iii) a Warrant Offering of up to 12M warrants at C$0.05 each for C$600,000. LIFE Offering purchasers must buy 0.714 Private Placement shares for each LIFE share. Warrants are exercisable at C$0.05 for 24 months, subject to shareholder approval. The offerings are expected to close around December 23, 2024. Proceeds will be used for working capital and general corporate purposes.
Trilogy AI Corp. (CSE: TRAI) has announced a share consolidation effective December 6, 2024. The consolidation will be conducted on a 4:1 basis, meaning one post-consolidated share will replace every four pre-consolidated shares. Following the consolidation, approximately 14,132,204 shares will be outstanding, subject to rounding adjustments. No fractional shares will be issued. The company's trading symbol remains 'TRAI', though a new CUSIP number (895979201) has been assigned. The transfer agent, Odyssey Trust Company, confirmed that shareholders of record will hold shares represented by a DRS statement, with the consolidation being conducted on a 'push-out' basis.
Trilogy AI Corp (CSE: TRAI) (OTCQB: TRAIF) has announced a 4:1 share consolidation, which will reduce its outstanding shares from 56,528,815 to approximately 14,132,204. The Board believes this consolidation will enhance financing opportunities and improve trading liquidity. Additionally, the company has appointed DJ Bowen as a Director, bringing over 20 years of expertise in quantitative trading, portfolio management, and financial software development.
FAQ
What is the current stock price of Trilogy AI (TRAIF)?
What is the market cap of Trilogy AI (TRAIF)?
